Please use this identifier to cite or link to this item: http://ri.uaemex.mx/handle20.500.11799/39412
DC FieldValueLanguage
dc.creatorFred Alonso López Durán-
dc.creatorMARTHA PEDRAZA LOPEZ-
dc.creatorCONSUELO ARTEAGA PEREZ-
dc.creatorDIANA EDITH HERNANDEZ HERNANDEZ-
dc.creatorROCIO ANGELES GARCIA BECERRA-
dc.creatorDAVID ORDAZ ROSADO-
dc.date2009-
dc.date.accessioned2022-04-21T05:12:09Z-
dc.date.available2022-04-21T05:12:09Z-
dc.identifierhttp://hdl.handle.net/20.500.11799/39412-
dc.identifier.urihttp://ri.uaemex.mx/handle20.500.11799/39412-
dc.descriptionThe multistep process of angiogenesis offers several targets for therapeutic interventions. One molecular target structure is the alfa five beta three (av b3 ) integrin which is expressed on vascular endothelial cells and over-expressed in cancer tumor angiogenesis. To image neoangiogenesis in athymic mice with induced pancreatic, breast and prostate malignant tumors a new radiopharmaceutical was developed. The 99mTc-EDDA/HYNIC-cyclic-Arg-Gly- Asp-D-Phe-Lys (99mTc-cRGD) targets integrin receptors av b3 and was prepared with an average radiochemical purity > 95 %. 99mTc-cRGD shows high in vivo stability, fast blood clearance and rapid renal excretion in mice. There are statistical differences between tumor/muscle ratios for the 3 tumors studied. The highest tumor/non-target ratio was found in breast cancer (7.2 after 24 h) and a representative dorsal SPECT image was obtained where the tumor showed up very clearly over the background tissue. The high resolution of the image implies that 99mTc-cRGD will be of great value in nuclear medicine as a potential radiopharmaceutical for av b3 integrins receptor uptake and for imaging neoangiogenesis in neoplastic tissue and to follow up cancer tumor progression.-
dc.formatapplication/application/pdf-
dc.languageeng-
dc.publisherAsociación Mexicana de Bioquímica Clínica, A.C.-
dc.relationhttp://www.redalyc.org/revista.oa?id=576-
dc.rightsinfo:eu-repo/semantics/openAccess-
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/4.0-
dc.sourceBioquimia (México) Num.2 Vol.34-
dc.subjectQuímica-
dc.subjectIntegrin av b3-
dc.subjectmolecular imaging-
dc.subjectangiogenesis-
dc.subjectinfo:eu-repo/classification/cti/2-
dc.titleRadiopharmacokinetics and uptake of 99m Tc-cRGD in av B3 integrins for imaging angiogenesis in induced malignant tumors in athymic mice-
dc.typearticle-
dc.audiencestudents-
dc.audienceresearchers-
item.grantfulltextnone-
item.fulltextNo Fulltext-
Appears in Collections:Producción
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.